1 / 2

e stradiol supplementation

e stradiol supplementation. Figure S1. Growth chart of the patient. Actual height of the patient is plotted against the growth curve for Japanese girls (the mean, ± 1.0 SD and ± 2.0 SD). p = 0.78. p = 0.06. p = 0.20. p = 0.97. p = 0.02. p = 3.2×10 -7. p = 1.2×10 -7.

ryann
Download Presentation

e stradiol supplementation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. estradiol supplementation Figure S1. Growth chart of the patient. Actual height of the patient is plotted against the growth curve for Japanese girls (the mean, ± 1.0 SD and ± 2.0 SD).

  2. p = 0.78 p = 0.06 p = 0.20 p = 0.97 p = 0.02 p = 3.2×10-7 p = 1.2×10-7 p = 1.1×10-4 p = 7.0×10-7 p = 1.1×10-13 Relative fold induction Relative fold induction p = 6.0×10-8 p = 2.0×10-7 WT (ng/well) 0 2020 100 WT (ng/well) 0 2020 100 MT (ng/well) 0 0 20 10 20 MT (ng/well) 0 0 20 10 20 PAX3 (-) PAX3 (+) Figure S2. In vitro reporter assay using a luciferase vector containing the MITF promoter. The SOX10 expression vectors were transfected with (right panel) or without (left panel) the PAX3 expression vector. The results are expressed as the mean ± one standard deviation. The p.Pro169fsX117 mutant (MT) barely transactivated the MITF promoter and exerted no dominant-negative effects on the wildtype (WT) SOX10 protein. As controls for the expression vectors, an empty counterpart vector was transfected.

More Related